Text Size

Ergospirometric Values and WBV in Elderly (EVAWIE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Maíra F Pessoa, Universidade Federal de Pernambuco
ClinicalTrials.gov Identifier:
NCT01681719
First received: August 30, 2012
Last updated: September 5, 2012
Last verified: September 2012
History of Changes
  Purpose

this study aims evaluate the ergospirometric values after 03 months of training with WBV in elderly health people. The hypothesis is increases of ergospirometric values.


Condition Intervention
Aging
 Device: WBV and Resistance
Device: resistance & sham WBV
Device: WBV & resistance sham

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Whole Body Vibration as Alternative for Improve the Ergospirometric Values in Elderly: a Randomized Clinical Trial

Further study details as provided by Universidade Federal de Pernambuco:

Primary Outcome Measures:
  • maximal O2 consumption [ Time Frame: started and finished the protocol after 03 months ] [ Designated as safety issue: No ]

Enrollment: 25
Study Start Date: January 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: WBV and resistance
used both interventions
 Device: WBV and Resistance

use of WBV and resistance device during 03 months in elderly health people. The WBV used progressive increases of time and amplitude and the resistance training improves the weight.

For Resistance: performed in upper and lower limbs in weight machine Mega II Movement®, used guidelines from American College of Sports Medicine for elderly, with two series of 08 repetitions (75% weight of one RM), considered for RM calculation the maximum voluntary isometric contraction.

For WBV: used MY3 platform (Power Plate®, MY3, UK) frequency 35 hertz, tri-axial, amplitude 02 mm in adaptation and initial phases, increasing to 04 mm in phases intermediate and final. The time initial was 10 minutes, progressed to 15 min in second month, concluding with 20 min. Rest time between series remained 01 min.
Experimental: WBV & resistance sham
used the vibrating platform and sham for resistance training
 Device: WBV & resistance sham

used really the WBV, but sham for resistance training

For Resistance: performed similar movments in upper and lower limbs in weight machine Mega II Movement®, without using weights.

For WBV: used MY3 platform (Power Plate®, MY3, UK) frequency 35 hertz, tri-axial, amplitude 02 mm in adaptation and initial phases, increasing to 04 mm in phases intermediate and final. The time initial was 10 minutes, progressed to 15 min in second month, concluding with 20 min. Rest time between series remained 01 min.
Experimental: Resistance & sham WBV
used resistance exercises and sham for vibrating platform
 Device: resistance & sham WBV

used only resistance

For Resistance: performed in upper and lower limbs in weight machine Mega II Movement®, used guidelines from American College of Sports Medicine for elderly, with two series of 08 repetitions (75% weight of one RM), considered for RM calculation the maximum voluntary isometric contraction.

For WBV: used MY3 platform (Power Plate®, MY3, UK)off.

  Eligibility

Ages Eligible for Study:   60 Years to 74 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • aged 60-74 years,
  • Sedentary or Moderate A in accord with IPAQ short form (International Physical Activity Questionnaire) and those without disease.
  • furthermore, the subjects should reach the ventilatory threshold 1, considered after meeting two of the following events:
  • respiratory quotient (R) increases (R ≥1,1);
  • loss of linearity between the pulmonary ventilation curve (VE) and oxygen consumption (VO2), plateau of VO2 or plateau of heart rate (HR) and increases of end-tidal PO2 (Pet O2)

Exclusion Criteria:

  • Were excluded subjects with changes in Mini-mental state examination (MMSE) scores by age and educational level where the minimum score represents: illiterate 13 points, less than 8 study years is 18 points, 8 or more study years is 26 points 11.
  • Were also excluded current smokers or previous, subjects with thrombosis, labyrinthitis, diabetes, hemodynamic instabilities, obesity, osteoporosis, neuromuscular diseases, pulmonary or cardiac diseases, changes in resting electrocardiogram or in exercise, ingestion of drugs to metabolism bone / muscle / heart chronotropism or with difficulties in adapting protocols
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01681719

Locations
Brazil
UFPE
Recife, Pernambuco, Brazil, 50740-560
Sponsors and Collaborators
Maíra F Pessoa
  More Information

No publications provided

Responsible Party: Maíra F Pessoa, Principal Investigator, Universidade Federal de Pernambuco
ClinicalTrials.gov Identifier: NCT01681719     History of Changes
Other Study ID Numbers: ERGOFORCE1
Study First Received: August 30, 2012
Last Updated: September 5, 2012
Health Authority: Brazil: Ethics Committee

Keywords provided by Universidade Federal de Pernambuco:
VO2
VCO2
VE/VO2
heart rate

ClinicalTrials.gov processed this record on June 13, 2013